135 related articles for article (PubMed ID: 27648370)
1. DNA integrity as biomarker in pancreatic cyst fluid.
Utomo WK; Janmaat VT; Verhaar AP; Cros J; Lévy P; Ruszniewski P; den Berg MS; Jenster G; Bruno MJ; Braat H; Fuhler GM; Peppelenbosch MP
Am J Cancer Res; 2016; 6(8):1837-41. PubMed ID: 27648370
[TBL] [Abstract][Full Text] [Related]
2. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
3. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
[TBL] [Abstract][Full Text] [Related]
5. The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma.
Shen Q; Cen H; Jiang J; Cong Z; Zhou Y; Huang X; Zhu L; Jiang Q; Xue C
Transl Cancer Res; 2022 Nov; 11(11):4137-4147. PubMed ID: 36523306
[TBL] [Abstract][Full Text] [Related]
6. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
Umetani N; Kim J; Hiramatsu S; Reber HA; Hines OJ; Bilchik AJ; Hoon DS
Clin Chem; 2006 Jun; 52(6):1062-9. PubMed ID: 16723681
[TBL] [Abstract][Full Text] [Related]
7. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.
Vizza E; Corrado G; De Angeli M; Carosi M; Mancini E; Baiocco E; Chiofalo B; Patrizi L; Zampa A; Piaggio G; Cicchillitti L
J Exp Clin Cancer Res; 2018 Jan; 37(1):16. PubMed ID: 29382392
[TBL] [Abstract][Full Text] [Related]
8. Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.
Zhu F; Ma J; Ru D; Wu N; Zhang Y; Li H; Liu X; Li J; Zhang H; Xu Y; Zhao J; Tang H; Wang Y; Fu W
J Oncol; 2021; 2021():5569783. PubMed ID: 34135960
[TBL] [Abstract][Full Text] [Related]
9. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
Yu D; An G; Xu L
Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease.
Kumar S; Nadda N; Paul S; Gamanagatti S; Dash NR; Vanamail P; Saraya A; Shalimar ; Nayak B
Front Mol Biosci; 2022; 9():1024193. PubMed ID: 36483538
[No Abstract] [Full Text] [Related]
14. Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence.
Fawzy A; Sweify KM; El-Fayoumy HM; Nofal N
J Egypt Natl Canc Inst; 2016 Dec; 28(4):235-242. PubMed ID: 27634416
[TBL] [Abstract][Full Text] [Related]
15. Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients.
Adusei E; Ahenkorah J; Adu-Aryee NA; Adutwum-Ofosu KK; Tagoe EA; Koney NK; Nkansah E; Aryee NA; Blay RM; Hottor BA; Clegg-Lamptey JN; Arko-Boham B
Med Sci (Basel); 2021 May; 9(2):. PubMed ID: 34070520
[TBL] [Abstract][Full Text] [Related]
16. The Significance of Circulating Cell-Free DNA Markers in Chronic Hepatitis B Patients with Hepatocellular Carcinoma.
Papatheodoridi A; Karakousis N; Lembessis P; Chatzigeorgiou A; Papatheodoridis GV
Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832679
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
18. Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients.
Anzinger I; Nagel D; De Toni EN; Ofner A; Philipp AB; Holdt LM; Teupser D; Kolligs FT; Herbst A
Cancer Biomark; 2023; 37(4):237-248. PubMed ID: 37302022
[TBL] [Abstract][Full Text] [Related]
19. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
